Related Experiment Video
Updated: Jun 16, 2026

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
Published on: March 26, 2018
Dependence receptors: a new paradigm in cell signaling and cancer therapy
1Apoptosis, Cancer and Development Laboratory- Equipe labellisée La Ligue, CNRS UMR5238, Centre Léon Bérard, Université de Lyon, Lyon, France.
Abstract:
Dependence receptors (DRs) now form a family of more than a dozen membrane receptors that are not linked by their structure, but by common functional traits. The most notable is their ability to trigger two opposite signaling pathways: in the presence of ligand, these receptors activate classic signaling pathways implicated in cell survival, migration and differentiation. In the absence of ligand, they do not stay inactive, rather they elicit an apoptotic signal. Thus, cells expressing this kind of receptor are dependent on the presence of ligand in the extracellular environment to survive. This review will recapitulate the increasing data regarding the molecular mechanisms associated with DRs, their potential implication during development, as well as their deregulation during tumorigenesis and, finally, their emergence as new possible therapeutic targets for cancer treatment.
Insights
Dependence receptors (DRs) trigger cell survival pathways with ligands but induce apoptosis without them. This highlights DRs
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Dependence receptors (DRs) are a family of membrane receptors characterized by a unique dual signaling capacity.
- These receptors activate pro-survival pathways in the presence of their ligand and initiate apoptosis in its absence.
- Cells expressing DRs are critically dependent on extracellular ligand availability for survival.
Purpose of the Study:
- To review the molecular mechanisms governing Dependence Receptor (DR) signaling.
- To explore the role of DRs in developmental processes.
- To discuss the implications of DR deregulation in tumorigenesis and their potential as cancer therapeutic targets.
Main Methods:
- Literature review of existing data on Dependence Receptors (DRs).
- Analysis of molecular mechanisms, developmental roles, and involvement in cancer.
- Evaluation of DRs as potential therapeutic targets.
Main Results:
- DRs exhibit context-dependent signaling, activating survival or apoptotic pathways based on ligand presence.
- DRs play significant roles during development.
- Dysregulation of DRs is implicated in various cancers, presenting them as novel therapeutic targets.
Conclusions:
- Dependence receptors (DRs) are crucial regulators of cell fate, linking ligand availability to survival or apoptosis.
- Understanding DRs' molecular mechanisms and roles in development and cancer is vital.
- DRs represent promising targets for future cancer therapies.
More Related Videos
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
08:04In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Published on: February 27, 2019
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Mitogens and the Cell Cycle
Cell Signaling in Plants
Types of Receptors: Cell Surface Receptors
Signal Transduction: Overview
Typically, signal transduction involves three...